首页 > 最新文献

Revista espanola de anestesiologia y reanimacion最新文献

英文 中文
How a single perioperative delirium case can make the difference 一个围手术期谵妄病例是如何产生影响的?
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.04.003

This report describes how postoperative delirium in an elderly man during COVID-19 pandemic led to a serious event involving a central venous catheter. Delirium is a common cause of perioperative morbidity and mortality, and is characterised by an alteration in consciousness and perception and a reduced ability to focus, sustain or shift attention. The event was analysed by a multidisciplinary committee which developed a risk stratification delirium protocol in order to prevent similar events in the future.

本报告描述了一名老人在 COVID-19 大流行期间因术后谵妄而导致涉及中心静脉导管的严重事件。谵妄是围手术期发病率和死亡率的常见原因,其特征是意识和感知发生改变,集中、维持或转移注意力的能力下降。多学科委员会对该事件进行了分析,并制定了谵妄风险分层协议,以防止今后发生类似事件。
{"title":"How a single perioperative delirium case can make the difference","authors":"","doi":"10.1016/j.redare.2024.04.003","DOIUrl":"10.1016/j.redare.2024.04.003","url":null,"abstract":"<div><p>This report describes how postoperative delirium<span><span> in an elderly man during COVID-19 pandemic led to a serious event involving a central venous catheter. Delirium is a common cause of perioperative morbidity and mortality, and is characterised by an alteration in consciousness and perception and a reduced ability to focus, sustain or shift attention. The event was analysed by a multidisciplinary committee which developed a </span>risk stratification delirium protocol in order to prevent similar events in the future.</span></p></div>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140781010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound monitoring to detect embolic phenomena in the inferior vena cava during hip arthroplasty 髋关节置换术中检测下腔静脉栓塞现象的超声监测。
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.04.017

Introduction and objectives

Embolic phenomena frequently occur during hip joint replacement surgery, and may lead to haemodynamic instability in frail patients. Transoesophageal ultrasound monitoring is rarely available in non-cardiac operating theatres, and cannot be performed in awake patients under spinal anaesthesia. The main objectives of this prospective exploratory study were to determine the feasibility of using an alternative ultrasound approach to monitor the inferior vena cava during hip replacement surgery, and to determine the intra and interobserver reliability of the ultrasound findings.

Method

We conducted a prospective exploratory study in 20 patients undergoing cemented hip arthroplasty in the supine position under spinal anaesthesia and sedation. The inferior vena cava was assessed through a subcostal window at 10 intraoperative time points, and the findings were rated on a qualitative embolism severity scale. The ultrasound images were evaluated by 2 independent observers.

Results

An adequate subcostal window was obtained in 90% of cases. Intra- and inter-observer reliability was high (kappa index >0.80, p < 0.001). Nearly all (95%) patients presented some degree of embolism, which was severe in 50% of cases.

Conclusions

Our study suggests that ultrasound assessment of embolic phenomena in the inferior vena cava through a subcostal window is feasible in 90% of cases. The qualitative embolic severity rating scale is highly reproducible and has high intra- and inter-observer reliability.

引言和目的:髋关节置换手术中经常出现栓塞现象,可能导致体弱患者血流动力学不稳定。经食道超声监测在非心脏手术室很少使用,而且无法在脊髓麻醉的清醒患者中进行。这项前瞻性探索研究的主要目的是确定在髋关节置换手术中使用另一种超声方法监测下腔静脉的可行性,并确定超声结果在观察者内部和观察者之间的可靠性:我们对 20 名在脊髓麻醉和镇静下仰卧位接受骨水泥髋关节置换术的患者进行了前瞻性探索研究。在术中的 10 个时间点,通过肋下开窗对下腔静脉进行评估,并根据栓塞严重程度定性评分。超声图像由两名独立观察员进行评估:结果:90%的病例都获得了充分的肋下开窗。观察者内部和观察者之间的可靠性都很高(卡帕指数大于 0.80,P 结论:我们的研究表明,超声检查对栓塞的诊断具有重要意义:我们的研究表明,在 90% 的病例中,通过肋下开窗对下腔静脉栓塞现象进行超声评估是可靠的。栓塞严重程度定性评分量表的可重复性很高,观察者内部和观察者之间的可靠性也很高。
{"title":"Ultrasound monitoring to detect embolic phenomena in the inferior vena cava during hip arthroplasty","authors":"","doi":"10.1016/j.redare.2024.04.017","DOIUrl":"10.1016/j.redare.2024.04.017","url":null,"abstract":"<div><h3>Introduction and objectives</h3><p><span>Embolic phenomena frequently occur during hip joint replacement surgery, and may lead to haemodynamic instability in frail patients. Transoesophageal ultrasound monitoring is rarely available in non-cardiac operating theatres, and cannot be performed in awake patients under </span>spinal anaesthesia<span><span>. The main objectives of this prospective exploratory study were to determine the feasibility of using an alternative ultrasound approach to monitor the inferior vena cava during </span>hip replacement surgery, and to determine the intra and interobserver reliability of the ultrasound findings.</span></p></div><div><h3>Method</h3><p><span>We conducted a prospective exploratory study in 20 patients undergoing cemented hip arthroplasty in the </span>supine position under spinal anaesthesia and sedation. The inferior vena cava was assessed through a subcostal window at 10 intraoperative time points, and the findings were rated on a qualitative embolism severity scale. The ultrasound images were evaluated by 2 independent observers.</p></div><div><h3>Results</h3><p>An adequate subcostal window was obtained in 90% of cases. Intra- and inter-observer reliability was high (kappa index &gt;0.80, p &lt; 0.001). Nearly all (95%) patients presented some degree of embolism, which was severe in 50% of cases.</p></div><div><h3>Conclusions</h3><p>Our study suggests that ultrasound assessment of embolic phenomena in the inferior vena cava through a subcostal window is feasible in 90% of cases. The qualitative embolic severity rating scale is highly reproducible and has high intra- and inter-observer reliability.</p></div>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
NRFit connectors in regional anaesthesia: avoiding medication errors 区域麻醉中的 NRFit 连接器:避免用药错误。
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.04.012

The continuous development of medicine in most fields requires physicians to apply the latest methods and technology to ensure patients’ safety. In the field of anesthesiology we are pioneers in the application of measures that guarantee the security of our patients, making possible the greatest reduction in mortality seen among all other specialties. This objective has been achieved thanks to the introduction of changes such as the one presented in this review article.

The specific NRFit® connections for neuraxial and other regional anesthesia applications prevent wrong route medication errors to occur. These medication errors have been related to a high morbidity and mortality rate. This article reviews this new technology based in our own two-year experience at Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid) as well as a literature review using PubMed, UpToDate and ClinicalKey.

医学在大多数领域的不断发展要求医生应用最新的方法和技术来确保病人的安全。在麻醉学领域,我们是应用保障病人安全措施的先驱,使死亡率在所有其他专科中降幅最大。这一目标的实现要归功于所引入的变革,例如本评论文章中介绍的变革。用于神经和其他区域麻醉应用的特定 NRFit® 连接可防止错误路径用药错误的发生。这些用药错误与高发病率和高死亡率有关。本文基于我们在阿斯图里亚斯普林西比大学医院(马德里,阿尔卡拉德埃纳雷斯)两年的经验,以及使用 PubMed、UpToDate 和 ClinicalKey 进行的文献综述,对这项新技术进行了回顾。
{"title":"NRFit connectors in regional anaesthesia: avoiding medication errors","authors":"","doi":"10.1016/j.redare.2024.04.012","DOIUrl":"10.1016/j.redare.2024.04.012","url":null,"abstract":"<div><p>The continuous development of medicine in most fields requires physicians to apply the latest methods and technology to ensure patients’ safety. In the field of anesthesiology we are pioneers in the application of measures that guarantee the security of our patients, making possible the greatest reduction in mortality seen among all other specialties. This objective has been achieved thanks to the introduction of changes such as the one presented in this review article.</p><p>The specific NRFit® connections for neuraxial and other regional anesthesia applications prevent wrong route medication errors to occur. These medication errors have been related to a high morbidity and mortality rate. This article reviews this new technology based in our own two-year experience at Hospital Universitario Príncipe de Asturias (Alcalá de Henares, Madrid) as well as a literature review using PubMed, UpToDate and ClinicalKey.</p></div>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2341192924000805/pdfft?md5=00199cae812f7357b90bed3c90416680&pid=1-s2.0-S2341192924000805-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140874126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sarcopenia measured by tomography as a predictor of morbidity and mortality in thoracic surgery, a retrospective cohort study 通过断层扫描测量的 "肌肉疏松症 "可预测胸外科手术的发病率和死亡率。一项回顾性队列研究。
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.05.001

Background

Sarcopenia has been identified as a risk factor for perioperative adverse events. Several studies have shown that tomographic assessment of muscle mass can be an appropriate indicator of sarcopenia associated with morbidity and mortality. The aim of the study was to determine the association between height-adjusted area of ​​the pectoral and erector spinae muscles (haPMA and haESA) and perioperative morbidity and mortality in thoracic surgery.

Methods

Retrospective cohort study. Measurement of muscle areas was performed by tomography. The outcomes were 30-day mortality and postoperative morbidity. The discriminative capacity of the muscle areas was evaluated with an analysis of ROC curves and the Youden index was used to establish a cut-off point. The raw morbidity and mortality risk was determined and adjusted for potential confounders.

Results

A total of 509 patients taken to thoracic surgery were included. The incidence of 30-day mortality was 7.3%. An association was found between muscle areas and 30-day mortality and pneumonia, with adequate discriminative power for mortality (AUC 0.68 for haPMA and 0.67 for haESA). An haPMA less than 10 and haESA less than 8.5 cm2/m2 were identified as a risk factor for 30-day mortality with an adjusted OR of 2.34 (95%CI 1.03–5.15) and 2.22 (95%CI 1.10–6.04) respectively.

Conclusions

Sarcopenia, defined as low muscle area in the pectoral and erector spinae muscles, is associated with increased morbidity and mortality in patients undergoing thoracic surgery.

背景:肌少症已被确定为围术期不良事件的一个风险因素。多项研究表明,肌肉质量断层扫描评估可作为与发病率和死亡率相关的肌肉疏松症的适当指标。本研究旨在确定胸廓手术中胸肌和竖脊肌的身高调整面积(haPMA 和 haESA)与围术期发病率和死亡率之间的关系:方法:回顾性队列研究。通过断层扫描测量肌肉面积。研究结果为 30 天死亡率和术后发病率。通过 ROC 曲线分析评估了肌肉面积的判别能力,并使用尤登指数确定了分界点。确定了原始发病率和死亡率风险,并对潜在的混杂因素进行了调整:结果:共纳入了 509 名接受胸外科手术的患者。30天死亡率为7.3%。研究发现,肌肉面积与 30 天死亡率和肺炎之间存在关联,对死亡率有足够的鉴别力(haPMA 的 AUC 为 0.68,haESA 为 0.67)。haPMA 小于 10 和 haESA 小于 8.5 cm2/m2 被确定为 30 天死亡率的风险因素,调整后 OR 分别为 2.34(95%CI 1.03 - 5.15)和 2.22(95%CI 1.10 - 6.04):胸廓手术患者的发病率和死亡率与肌肉疏松症(定义为胸肌和竖脊肌的肌肉面积较小)的增加有关。
{"title":"Sarcopenia measured by tomography as a predictor of morbidity and mortality in thoracic surgery, a retrospective cohort study","authors":"","doi":"10.1016/j.redare.2024.05.001","DOIUrl":"10.1016/j.redare.2024.05.001","url":null,"abstract":"<div><h3>Background</h3><p>Sarcopenia<span><span> has been identified as a risk factor for perioperative adverse events. Several studies have shown that tomographic assessment of muscle mass can be an appropriate indicator of sarcopenia associated with morbidity and mortality. The aim of the study was to determine the association between height-adjusted area of ​​the pectoral and erector spinae muscles (haPMA and haESA) and perioperative morbidity and mortality in </span>thoracic surgery.</span></p></div><div><h3>Methods</h3><p><span>Retrospective cohort study. Measurement of muscle areas was performed by </span>tomography<span>. The outcomes were 30-day mortality and postoperative morbidity. The discriminative capacity of the muscle areas was evaluated with an analysis of ROC curves and the Youden index was used to establish a cut-off point. The raw morbidity and mortality risk was determined and adjusted for potential confounders.</span></p></div><div><h3>Results</h3><p>A total of 509 patients taken to thoracic surgery were included. The incidence of 30-day mortality was 7.3%. An association was found between muscle areas and 30-day mortality and pneumonia, with adequate discriminative power for mortality (AUC 0.68 for haPMA and 0.67 for haESA). An haPMA less than 10 and haESA less than 8.5 cm<sup>2</sup>/m<sup>2</sup> were identified as a risk factor for 30-day mortality with an adjusted OR of 2.34 (95%CI 1.03–5.15) and 2.22 (95%CI 1.10–6.04) respectively.</p></div><div><h3>Conclusions</h3><p>Sarcopenia, defined as low muscle area in the pectoral and erector spinae muscles, is associated with increased morbidity and mortality in patients undergoing thoracic surgery.</p></div>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140892988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative hypotension: Is intraoperative use of dexmedetomidine safe in frail patients? 术后低血压:术中使用右美托咪定对体弱患者安全吗?
Pub Date : 2024-08-01 Epub Date: 2024-05-14 DOI: 10.1016/j.redare.2024.05.002
D Lopez-Lopez, R Mato-Bua, P Neira-Somoza, E Turrado-Blanco
{"title":"Postoperative hypotension: Is intraoperative use of dexmedetomidine safe in frail patients?","authors":"D Lopez-Lopez, R Mato-Bua, P Neira-Somoza, E Turrado-Blanco","doi":"10.1016/j.redare.2024.05.002","DOIUrl":"10.1016/j.redare.2024.05.002","url":null,"abstract":"","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140961383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chest compressions as a rescue manoeuvre to maintain aortic valve opening during left ventricular distention syndrome on venoarterial ECMO 在静脉-动脉 ECMO 患者出现左心室扩张综合征时,将胸外按压作为维持主动脉瓣开放的抢救手段。
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.02.028
{"title":"Chest compressions as a rescue manoeuvre to maintain aortic valve opening during left ventricular distention syndrome on venoarterial ECMO","authors":"","doi":"10.1016/j.redare.2024.02.028","DOIUrl":"10.1016/j.redare.2024.02.028","url":null,"abstract":"","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2341192924000507/pdfft?md5=acda3bb576551bf42fea21a0139ee4ca&pid=1-s2.0-S2341192924000507-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140013880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study 接受心脏手术的急性肾损伤高危患者的尿酸和急性肾损伤:一项前瞻性多中心研究。
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.04.019

Purpose

It is unclear whether preoperative serum uric acid (SUA) elevation may play a role in the development of acute kidney injury (AKI) associated with cardiac surgery (CSA-AKI). We conducted a cohort study to evaluate the influence of preoperative hyperuricemia on AKI in patients at high risk for developing SC-AKI.

Design

Multicenter prospective international cohort study.

Setting

Fourteen university hospitals in Spain and the United Kingdom.

Participants

We studied 261 consecutive patients at high risk of developing CSA-AKI, according to a Cleveland score ≥ 4 points, from July to December 2017.

Interventions

None.

Measurements and main results

AKIN criteria were used for the definition of AKI. Multivariable logistic regression models and propensity score-matched pairwise analysis were used to determine the adjusted association between preoperative hyperuricemia (≥7 mg/dL) and AKI. Elevated preoperative AUS (≥7 mg/dL) was present in 190 patients (72.8%), whereas CSA-AKI occurred in 145 patients (55.5%). In multivariable logistic regression models, hyperuricemia was not associated with a significantly increased risk of AKI (adjusted Odds Ratio [OR]: 1.58; 95% confidence interval [CI]: 0.81–3; P = .17). In propensity score-matched analysis of 140 patients, the hyperuricemia group experienced similar adjusted odds of AKI (OR 1.05, 95%CI 0.93–1.19, P = .37).

Conclusions

Hyperuricemia was not associated with an increased risk of AKI in this cohort of patients undergoing cardiac surgery at high risk of developing CSA-AKI.

目的:目前尚不清楚术前血清尿酸(SUA)升高是否会在心脏手术相关急性肾损伤(AKI)(CSA-AKI)的发生中发挥作用。我们进行了一项队列研究,以评估术前高尿酸血症对罹患 SC-AKI 高风险患者 AKI 的影响:多中心前瞻性国际队列研究:地点:西班牙和英国的 14 家大学医院:2017年7月至12月,根据克利夫兰评分≥4分,我们连续研究了261名CSA-AKI高危患者:无:采用AKIN标准定义AKI。采用多变量逻辑回归模型和倾向得分匹配配对分析来确定术前高尿酸血症(≥7 mg/dL)与 AKI 之间的调整关联。190例患者(72.8%)术前AUS升高(≥7 mg/dL),145例患者(55.5%)发生CSA-AKI。在多变量逻辑回归模型中,高尿酸血症与 AKI 风险的显著增加无关(调整后的比值比 [OR]:1.58; 95% 置信区间 [CI]:0.81-3; p = 0.17).在对140名患者进行倾向评分匹配分析时,高尿酸血症组发生AKI的调整后几率相似(OR 1.05,95%CI 0.93-1.19,P = 0.37):结论:在这批接受心脏手术的高危患者中,高尿酸血症与AKI风险增加无关。
{"title":"Uric acid and acute kidney injury in high-risk patients for developing acute kidney injury undergoing cardiac surgery: A prospective multicenter study","authors":"","doi":"10.1016/j.redare.2024.04.019","DOIUrl":"10.1016/j.redare.2024.04.019","url":null,"abstract":"<div><h3>Purpose</h3><p>It is unclear whether preoperative serum uric acid (SUA) elevation may play a role in the development of acute kidney injury (AKI) associated with cardiac surgery (CSA-AKI). We conducted a cohort study to evaluate the influence of preoperative hyperuricemia on AKI in patients at high risk for developing SC-AKI.</p></div><div><h3>Design</h3><p>Multicenter prospective international cohort study.</p></div><div><h3>Setting</h3><p>Fourteen university hospitals in Spain and the United Kingdom.</p></div><div><h3>Participants</h3><p>We studied 261 consecutive patients at high risk of developing CSA-AKI, according to a Cleveland score ≥ 4 points, from July to December 2017.</p></div><div><h3>Interventions</h3><p>None.</p></div><div><h3>Measurements and main results</h3><p>AKIN criteria were used for the definition of AKI. Multivariable logistic regression models and propensity score-matched pairwise analysis were used to determine the adjusted association between preoperative hyperuricemia (≥7 mg/dL) and AKI. Elevated preoperative AUS (≥7 mg/dL) was present in 190 patients (72.8%), whereas CSA-AKI occurred in 145 patients (55.5%). In multivariable logistic regression models, hyperuricemia was not associated with a significantly increased risk of AKI (adjusted Odds Ratio [OR]: 1.58; 95% confidence interval [CI]: 0.81–3; <em>P</em> = .17). In propensity score-matched analysis of 140 patients, the hyperuricemia group experienced similar adjusted odds of AKI (OR 1.05, 95%CI 0.93–1.19, <em>P</em> = .37).</p></div><div><h3>Conclusions</h3><p>Hyperuricemia was not associated with an increased risk of AKI in this cohort of patients undergoing cardiac surgery at high risk of developing CSA-AKI.</p></div>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2341192924000945/pdfft?md5=9a8b8e2737e1d6073f070e2026e306ad&pid=1-s2.0-S2341192924000945-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postoperative hypotension: Is intraoperative use of dexmedetomidine safe in frail patients? 术后低血压:术中使用右美托咪定对体弱患者安全吗?
Pub Date : 2024-08-01 DOI: 10.1016/j.redare.2024.05.002
{"title":"Postoperative hypotension: Is intraoperative use of dexmedetomidine safe in frail patients?","authors":"","doi":"10.1016/j.redare.2024.05.002","DOIUrl":"10.1016/j.redare.2024.05.002","url":null,"abstract":"","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141044441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors for PPCs in laparoscopic non-robotic vs. laparoscopic robotic abdominal surgery (LapRas): rationale and protocol for a patient-level analysis of LAS VEGAS and AVATaR. 腹腔镜非机器人腹部手术 (LapRas) 与腹腔镜机器人腹部手术 (LapRas) 中 PPC 的风险因素:LAS VEGAS 和 AVATaR 患者层面分析的原理和方案。
Pub Date : 2024-07-08 DOI: 10.1016/j.redare.2024.07.001
S C Serafini, S N T Hemmes, A Serpa Neto, M J Schultz, E Tschernko, M Gama de Abreu, G Mazzinari, L Ball

Introduction: Postoperative pulmonary complications (PPCs) vary amongst different surgical techniques. We aim to compare the incidence of PPCs after laparoscopic non-robotic versus laparoscopic robotic abdominal surgery.

Methods and analysis: LapRas (Risk Factors for PPCs in Laparoscopic Non-robotic vs Laparoscopic robotic abdominal surgery) incorporates harmonized data from 2 observational studies on abdominal surgery patients and PPCs: 'Local ASsessment of VEntilatory management during General Anaesthesia for Surgery' (LAS VEGAS), and 'Assessment of Ventilation during general AnesThesia for Robotic surgery' (AVATaR). The primary endpoint is the occurrence of one or more PPCs in the first five postoperative days. Secondary endpoints include the occurrence of each individual PPC, hospital length of stay and in-hospital mortality. Logistic regression models will be used to identify risk factors for PPCs in laparoscopic non-robotic versus laparoscopic robotic abdominal surgery. We will investigate whether differences in the occurrence of PPCs between the two groups are driven by differences in duration of anesthesia and/or the intensity of mechanical ventilation.

Ethics and dissemination: This analysis will address a clinically relevant research question comparing laparoscopic and robotic assisted surgery. No additional ethical committee approval is required for this metanalysis. Data will be shared with the scientific community by abstracts and original articles submitted to peer-reviewed journals.

Registration: The registration of this post-hoc analysis is pending; individual studies that were merged into the used database were registered at clinicaltrials.gov: LAS VEGAS with identifier NCT01601223, AVATaR with identifier NCT02989415.

简介:不同手术技术的术后肺部并发症(PPCs)各不相同。我们旨在比较腹腔镜非机器人与腹腔镜机器人腹部手术后肺部并发症的发生率:LapRas(腹腔镜非机器人与腹腔镜机器人腹部手术 PPCs 的风险因素)整合了两项腹部手术患者和 PPCs 观察性研究的统一数据:"手术全身麻醉期间通气管理的局部评估"(LAS VEGAS)和 "机器人手术全身麻醉期间通气评估"(AVATaR)。主要终点是术后前五天内出现一种或多种 PPC。次要终点包括每种 PPC 的发生率、住院时间和院内死亡率。我们将使用逻辑回归模型来确定腹腔镜非机器人腹部手术与腹腔镜机器人腹部手术发生 PPC 的风险因素。我们将研究麻醉时间和/或机械通气强度的不同是否会导致两组间发生 PPCs 的差异:这项分析将解决一个与临床相关的研究问题,对腹腔镜手术和机器人辅助手术进行比较。这项荟萃分析无需获得伦理委员会的额外批准。数据将通过向同行评审期刊提交摘要和原创文章的方式与科学界共享:这项事后分析的注册工作尚未完成;合并到所用数据库中的单项研究已在 clinicaltrials.gov 注册:LAS VEGAS 的标识符为 NCT01601223,AVATaR 的标识符为 NCT02989415。
{"title":"Risk factors for PPCs in laparoscopic non-robotic vs. laparoscopic robotic abdominal surgery (LapRas): rationale and protocol for a patient-level analysis of LAS VEGAS and AVATaR.","authors":"S C Serafini, S N T Hemmes, A Serpa Neto, M J Schultz, E Tschernko, M Gama de Abreu, G Mazzinari, L Ball","doi":"10.1016/j.redare.2024.07.001","DOIUrl":"10.1016/j.redare.2024.07.001","url":null,"abstract":"<p><strong>Introduction: </strong>Postoperative pulmonary complications (PPCs) vary amongst different surgical techniques. We aim to compare the incidence of PPCs after laparoscopic non-robotic versus laparoscopic robotic abdominal surgery.</p><p><strong>Methods and analysis: </strong>LapRas (Risk Factors for PPCs in Laparoscopic Non-robotic vs Laparoscopic robotic abdominal surgery) incorporates harmonized data from 2 observational studies on abdominal surgery patients and PPCs: 'Local ASsessment of VEntilatory management during General Anaesthesia for Surgery' (LAS VEGAS), and 'Assessment of Ventilation during general AnesThesia for Robotic surgery' (AVATaR). The primary endpoint is the occurrence of one or more PPCs in the first five postoperative days. Secondary endpoints include the occurrence of each individual PPC, hospital length of stay and in-hospital mortality. Logistic regression models will be used to identify risk factors for PPCs in laparoscopic non-robotic versus laparoscopic robotic abdominal surgery. We will investigate whether differences in the occurrence of PPCs between the two groups are driven by differences in duration of anesthesia and/or the intensity of mechanical ventilation.</p><p><strong>Ethics and dissemination: </strong>This analysis will address a clinically relevant research question comparing laparoscopic and robotic assisted surgery. No additional ethical committee approval is required for this metanalysis. Data will be shared with the scientific community by abstracts and original articles submitted to peer-reviewed journals.</p><p><strong>Registration: </strong>The registration of this post-hoc analysis is pending; individual studies that were merged into the used database were registered at clinicaltrials.gov: LAS VEGAS with identifier NCT01601223, AVATaR with identifier NCT02989415.</p>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiofrequency of suprascapular nerve as an analgesic strategy for chronic pain management. Systematic review and meta-analysis. 肩胛上神经射频治疗作为慢性疼痛治疗的一种镇痛策略。
Pub Date : 2024-07-08 DOI: 10.1016/j.redare.2024.07.006
J Sebastián Infante, N Blackburn, J Felipe Vargas

Introduction: Chronic shoulder pain is highly prevalent in the general population. Many different analgesic strategies have been described, including radiofrequency treatment to the suprascapular nerve (RFS); however, the effectiveness this approach remains unclear, and no strong recommendation can be made. The aim of this systematic review is to analyse the latest clinical trials evaluating the effectiveness of RFS techniques applied to the suprascapular nerve in terms of management of chronic shoulder pain, post-procedural functionality, and adverse effects.

Methods: We performed a systematic review of clinical trials retrieved from Medline, Embase and the CENTRAL databases. We included trials comparing RFS with other strategies, including placebo, that had as their primary outcome measures pain rated on a visual analogue scale, functionality rated on a shoulder pain and disability index (SPADI), and the incidence of adverse events. Risk of bias was analysed using the Cochrane RoB2 tool. Evidence was analysed using a random effects model and heterogeneity was quantified using the I2 test.

Results: We identified 3030 trials, of which 8 met the inclusion criteria (n = 408). Seven had a high risk of bias. Pain intensity at 1 and 3 months was lower in patients receiving RFS, with a standardised mean difference (SMD) of -0.9 (95% CI [-1.1, 0.33], p = 0.29; I2 88%, p < 0.001) and -1.17 (95% CI [-2.49, 0.14], p = 0.08; I2 97%, p < 0.001), respectively. Functional compromise at 1 and 3 months decreased in patients receiving RFS, with an SMD of -0.31 (95% CI [-0.91, 0.29], p = 0.31; I2 80%, p < 0.001) and -1.54 (95% CI [-3.26, 0.19], p = 0.08; I2 98%, p < 0.001), respectively. No RFS-related adverse events were described.

Conclusion: The evidence suggests that RFS reduces pain and improves functionality. However, the certainty of the evidence is low.

简介慢性肩痛在普通人群中非常普遍。目前已有许多不同的镇痛策略,包括肩胛上神经射频治疗(RFS);但是,这种方法的有效性仍不明确,也无法提出有力的建议。本系统性综述旨在分析最新的临床试验,评估应用于肩胛上神经的射频治疗技术在治疗慢性肩痛、术后功能和不良反应方面的有效性:我们对从 Medline、Embase 和 CENTRAL 数据库中检索到的临床试验进行了系统性回顾。我们纳入了将 RFS 与包括安慰剂在内的其他策略进行比较的试验,这些试验的主要结果指标包括视觉模拟量表评定的疼痛、肩痛与残疾指数 (SPADI) 评定的功能以及不良反应的发生率。使用 Cochrane RoB2 工具分析了偏倚风险。使用随机效应模型对证据进行分析,并使用 I2 检验对异质性进行量化:我们确定了 3030 项试验,其中 8 项符合纳入标准(n = 408)。其中 7 项存在高偏倚风险。接受RFS治疗的患者在1个月和3个月时的疼痛强度较低,标准化平均差异(SMD)为-0.9(95% CI [-1.1, 0.33],P = 0.29;I2 88%,P 2 80%,P 2 98%,P 结论:证据表明,RFS 可减轻疼痛并改善功能。然而,证据的确定性较低。
{"title":"Radiofrequency of suprascapular nerve as an analgesic strategy for chronic pain management. Systematic review and meta-analysis.","authors":"J Sebastián Infante, N Blackburn, J Felipe Vargas","doi":"10.1016/j.redare.2024.07.006","DOIUrl":"10.1016/j.redare.2024.07.006","url":null,"abstract":"<p><strong>Introduction: </strong>Chronic shoulder pain is highly prevalent in the general population. Many different analgesic strategies have been described, including radiofrequency treatment to the suprascapular nerve (RFS); however, the effectiveness this approach remains unclear, and no strong recommendation can be made. The aim of this systematic review is to analyse the latest clinical trials evaluating the effectiveness of RFS techniques applied to the suprascapular nerve in terms of management of chronic shoulder pain, post-procedural functionality, and adverse effects.</p><p><strong>Methods: </strong>We performed a systematic review of clinical trials retrieved from Medline, Embase and the CENTRAL databases. We included trials comparing RFS with other strategies, including placebo, that had as their primary outcome measures pain rated on a visual analogue scale, functionality rated on a shoulder pain and disability index (SPADI), and the incidence of adverse events. Risk of bias was analysed using the Cochrane RoB2 tool. Evidence was analysed using a random effects model and heterogeneity was quantified using the I<sup>2</sup> test.</p><p><strong>Results: </strong>We identified 3030 trials, of which 8 met the inclusion criteria (n = 408). Seven had a high risk of bias. Pain intensity at 1 and 3 months was lower in patients receiving RFS, with a standardised mean difference (SMD) of -0.9 (95% CI [-1.1, 0.33], p = 0.29; I<sup>2</sup> 88%, p < 0.001) and -1.17 (95% CI [-2.49, 0.14], p = 0.08; I<sup>2</sup> 97%, p < 0.001), respectively. Functional compromise at 1 and 3 months decreased in patients receiving RFS, with an SMD of -0.31 (95% CI [-0.91, 0.29], p = 0.31; I<sup>2</sup> 80%, p < 0.001) and -1.54 (95% CI [-3.26, 0.19], p = 0.08; I<sup>2</sup> 98%, p < 0.001), respectively. No RFS-related adverse events were described.</p><p><strong>Conclusion: </strong>The evidence suggests that RFS reduces pain and improves functionality. However, the certainty of the evidence is low.</p>","PeriodicalId":94196,"journal":{"name":"Revista espanola de anestesiologia y reanimacion","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141581966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista espanola de anestesiologia y reanimacion
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1